Is blood transfusion therapy the ideal treatment for ?-Thalassemia Intermedia?
The thalassemias represent the most common single gene disorder worldwide. The total annual incidence of symptomatic individuals with ?-thalassemia is estimated at 1 in 100,000 throughout the world (1) of which nearly 10% have ?-thalassemia intermedia (TI) (2). Several approaches have been used for...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
PAGEPress Publications
2014-08-01
|
| Serija: | Mediterranean Journal of Hematology and Infectious Diseases |
| Teme: | |
| Online pristup: | https://mjhid.org/index.php/mjhid/article/view/1685 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|